These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10264741)

  • 21. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people.
    Garfinkel D; Zur-Gil S; Ben-Israel J
    Isr Med Assoc J; 2007 Jun; 9(6):430-4. PubMed ID: 17642388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gap analysis: assessing the value perception of consultant pharmacist services and the performance of consultant pharmacists.
    Clark TR
    Consult Pharm; 2008 Sep; 23 Suppl C():3-15. PubMed ID: 19032018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing.
    Crotty M; Halbert J; Rowett D; Giles L; Birks R; Williams H; Whitehead C
    Age Ageing; 2004 Nov; 33(6):612-7. PubMed ID: 15385274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Improving blood pressure control with physician/pharmacist collaboration].
    Carter BL
    Vnitr Lek; 2009 Apr; 55(4):389-94. PubMed ID: 19449756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multidisciplinary approach to monitoring adverse drug reactions in a long-term care facility.
    Kehoe WA
    Hosp Pharm; 1985 Jul; 20(7):518-21, 525. PubMed ID: 10272732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
    Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
    Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A consultant pharmacist's use of a portable microcomputer at several skilled nursing facilities.
    Kohll DG; Young WW
    Hosp Pharm; 1986 Oct; 21(10):943-6, 953-4. PubMed ID: 10278984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the need for pharmacist-conducted drug regimen reviews in skilled nursing and intermediate care facilities.
    McGhan WF; Wertheimer AI; Marttila JK
    Contemp Pharm Pract; 1980; 3(4):203-9. PubMed ID: 10298036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary artery disease and hypertension: outcomes of a pharmacist-managed blood pressure program.
    McConnell KJ; Zadvorny EB; Hardy AM; Delate T; Rasmussen JR; Merenich JA;
    Pharmacotherapy; 2006 Sep; 26(9):1333-41. PubMed ID: 16945056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.
    Kucukarslan SN; Peters M; Mlynarek M; Nafziger DA
    Arch Intern Med; 2003 Sep; 163(17):2014-8. PubMed ID: 14504113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive benefits of a pharmacist-managed hypertension clinic in Nigeria.
    Erhun WO; Agbani EO; Bolaji EE
    Public Health; 2005 Sep; 119(9):792-8. PubMed ID: 15990127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consulting pharmacist services: evaluation by long-term care facility administrators.
    Evens RP; McCulloch-Turner P
    Hosp Formul; 1986 Feb; 21(2):220-8. PubMed ID: 10275577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacist intervention program for control of hypertension.
    Chabot I; Moisan J; Grégoire JP; Milot A
    Ann Pharmacother; 2003 Sep; 37(9):1186-93. PubMed ID: 12921497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the impact of education by a clinical pharmacist on antibiotic prescribing and administration in an acute care state psychiatric hospital.
    Thompson BF; Miller WA; Wells BG; Rawls WN
    Hosp Pharm; 1986 Nov; 21(11):1056-62. PubMed ID: 10279323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital.
    Bremberg ER; Hising C; Nylén U; Ehrsson H; Eksborg S
    J Oncol Pharm Pract; 2006 Jun; 12(2):75-81. PubMed ID: 16984745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. the consultant pharmacist and analgesic/anti-inflammatory drug usage in a geriatric long-term facility.
    Wilcher DE; Cooper JW
    J Am Geriatr Soc; 1981 Sep; 29(9):429-32. PubMed ID: 6167606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.